排序方式:
    總頁 1 
      Go

    1.Novel nano-drug delivery system for natural products and their application

    Huang, Li, Huang, Xu     More...

    Pharmacological Research[1043-6618], Published 2024, Volume 201,

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 16  2023影響因子:  9.1 

    2.Down-regulating Nrf2 by tangeretin reverses multiple drug resistance to both chemotherapy and EGFR tyrosine kinase inhibitors in lung cancer

    Xie, Y, Feng, SL, He     More...

    PHARMACOLOGICAL RESEARCH[1043-6618], Published 2022, Volume 186,

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 11  2023影響因子:  9.1  发表年影響因子:  9.3 

    3.Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8+ T cells

    Jiang, ZeBo, Xu, Con     More...

    Pharmacological Research[1043-6618], Published 2021, Volume 169,

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 17  2023影響因子:  9.1  发表年影響因子:  10.334 

    4.Metabolomics and integrated network pharmacology analysis reveal Tricin as the active anti-cancer component of Weijing decoction by suppression of PRKCA and sphingolipid signaling

    Li, JX, Li, RZ, Sun,     More...

    PHARMACOLOGICAL RESEARCH[1043-6618], Published 2021, Volume 171,

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 37  2023影響因子:  9.1  发表年影響因子:  10.334 

    顯示      條  合計   4   條
      總頁 1 
        Go

      本系統需要使用 Internet Explorer 9.0 以上Firefox || Chrome瀏覽器

      Copyright © 2018 澳門科技大學學者庫